LETTER
Na]: 301.1780; found: 301.1776.
Total Syntheses of the Sesquiterpenes
1201
HRMS: m/z calcd for C15H20O2Na [M + Na]: 255.1361;
found: 255.1360.
Compound 1: IR (neat): nmax = 1492, 1262, 1199, 814 cm–1.
1H NMR (300 MHz, CDCl3): d = 6.86 (1 H, d, J = 8.1 Hz),
6.83 (1 H, s), 6.58 (1 H, d, J = 8.1 Hz), 2.50–2.14 (3 H, m),
2.25 (3 H, s), 2.10–1.90 (2 H, m), 1.65 (3 H, s), 1.14 (3 H, d,
J = 6.6 Hz), 1.03 (3 H, d, J = 6.9 Hz). 13C NMR (75 MHz,
CDCl3): d = 150.1 (C), 128.6 (C), 128.5 (C), 128.4 (CH),
123.8 (CH), 116.1 (CH), 106.6 (C), 87.7 (C), 38.9 (CH2),
38.1 (CH2), 30.4 (CH), 24.3 (CH3), 21.0 (CH3), 18.6 (CH3),
16.8 (CH3). HRMS: m/z calcd for C15H20O2Na [M + Na]:
255.1361; found: 255.1359.
Compound 4: IR (neat): nmax = 1624, 1386, 1167, 1078
cm–1. 1H NMR (400 MHz, CDCl3): d = 6.95 (1 H, d, J = 8.0
Hz), 6.63 (1 H, d, J = 8.0 Hz), 6.56 (1 H, s), 2.25 (3 H, s),
2.60–2.20 (4 H, m), 2.10–1.90 (1 H, m), 1.66 (3 H, s), 1.13
(3 H, d, J = 6.9 Hz), 1.03 (3 H, d, J = 6.9 Hz). 13C NMR (100
MHz, CDCl3): d = 152.2 (C), 137.9 (C), 126.0 (C), 123.3
(CH), 120.5 (CH) 116.8 (CH), 106.9 (C), 87.8 (C), 38.9
(CH2), 38.2 (CH2), 30.6 (CH), 24.2 (CH3), 21.1 (CH3), 18.5
(CH3), 16.8 (CH3). HRMS: m/z calcd for C15H20O2Na [M +
Na]: 255.1361; found: 255.1359.
Bis-MOM ether 14: IR (neat): nmax = 1613, 1151, 1016, 923,
817 cm–1. 1H NMR (400 MHz, CDCl3): d 7.30 (1 H, d, J =
8.0 Hz), 6.90 (1 H, s), 6.76 (1 H, d, J = 8.0 Hz), 5.73 (1 H,
ddt, J = 16.8, 10.4, 6.4 Hz), 5.17 (2 H, s, OCH2O), 4.90 (1 H,
d, J = 16.8 Hz), 4.84 (1 H, d, J = 10.4 Hz), 4.75 and 4.70 (2
H, 2 × d, J = 7.2 Hz), 3.47 (3 H, s), 3.41 (3 H, s), 2.32 (3 H,
(6) Cuong, N. M.; Soejarto, D. D.; Pezzuto, J. M.; Fong, H. H.
S. J. Nat. Prod. 2003, 66, 609.
(7) Although litseachromolaevane A (10) was reported as a new
compound in 2003, it is the same as sesquichamaenol
reported earlier from Chamaecyparis forrnosensis Matsum.
See: Ando, M.; Ibe, S.; Kagabu, S.; Nakagawa, T.; Asao, T.;
Takase, K. J. Chem. Soc., Chem. Commun. 1970, 1538.
(8) Nemoto, H.; Miyata, J.; Fukumoto, K. Tetrahedron 1996,
52, 10363.
s), 2.20–1.90 (3 H, m), 1.86–1.70 (1 H, m), 1.68 (3 H, s). 13
C
NMR (100 MHz, CDCl3): d = 154.3 (C), 139.1 (CH), 138.1
(C), 130.0 (C), 127.8 (CH), 122.0 (CH), 115.1 (CH), 113.8
(CH2), 93.9 (CH2), 91.6 (CH2), 80.3 (C), 56.0 (CH3), 55.4
(CH3), 39.1 (CH2), 28.7 (CH2), 24.7 (CH3), 21.2 (CH3).
HRMS: m/z calcd for C17H26O4Na [M + Na]: 317.1729;
found: 317.1717.
(9) In the 1H NMR spectrum of the synthetic sample 2, it was
found that signals due to four methyl groups and two
aromatic protons were identical to those reported in the
literature for the natural compound 2. Since one of the
aromatic resonances (d = 6.59 ppm, d) did not match that
reported (d = 6.89 ppm, d) for 2 [reported in the literature2 on
the basis of the NMR spectrum of a 1:3 mixture (80% pure)
of 2 and 1, where the compound 2 is minor component], the
1H NMR spectrum of a ca. 3:1 mixture of 1 and 2 was
recorded and confirmed that the reported resonance at d =
6.89 ppm is not due to 2. To rule out the other possible
regioisomers completely, synthesis of compounds 3 and 4
were also accomplished5 starting from 2-hydroxy-5-
methylacetophenones and 2-hydroxy-4-methylisobutyro-
phenones employing the same sequence of reactions as
depicted in Schemes 1 and 3, respectively. The 1H NMR and
13C NMR spectra5 of compounds 3 and 4 were found to be
different from those reported in the literature2 for the
compound 2 (Scheme 4).
Ketone 17: IR (neat): nmax = 1711, 1613, 1150, 1015, 923,
817 cm–1. 1H NMR (400 MHz, CDCl3): d = 7.30 (1 H, d, J =
7.9 Hz), 6.89 (1 H, s), 6.75 (1 H, d, J = 7.9 Hz), 5.15 (2 H,
s), 4.73 and 4.71 (2 H, 2 × d, J = 7.2 Hz), 3.45 (3 H, s), 3.39
(3 H, s), 2.50–2.35 (3 H, m), 2.30 (3 H, s), 2.15–2.07 (2 H,
m), 1.66 (3 H, s), 1.00 (3 H, d, J = 6.9 Hz), 0.95 (3 H, d, J =
6.9 Hz). 13C NMR (100 MHz, CDCl3): d = 214.3 (C), 154.0
(C), 138.2 (C), 129.8 (C), 127.5 (CH), 121.9 (CH), 115.2
(CH), 94.0 (CH2), 91.4 (CH2), 79.8 (C), 56.0 (CH3), 55.4
(CH3), 40.8 (CH), 35.6 (CH2), 33.3 (CH2), 24.7 (CH3), 21.2
(CH3), 18.3 (CH3), 18.2 (CH3). HRMS: m/z calcd for
C19H30O5Na [M + Na]: 361.1991; found: 361.1990.
Compound 2: IR (neat): nmax = 1624, 1303, 1160, 907, 802
cm–1. 1H NMR (400 MHz, CDCl3): d = 6.89 (1 H, d, J = 7.9
Hz), 6.59 (1 H, d, J = 7.9 Hz), 6.56 (1 H, s), 2.26 (3 H, s),
2.20–2.08 (4 H, m), 1.90–1.83 (1 H, m), 1.69 (3 H, s), 1.09
(3 H, d, J = 6.7 Hz), 1.08 (3 H, d, J = 6.8 Hz). 13C NMR (100
MHz, CDCl3): d = 151.5 (C), 138.2 (C), 126.5 (C), 122.6
(CH), 120.4 (CH), 116.4 (CH), 111.0 (C), 82.6 (C), 42.8
(CH2), 34.9 (CH2), 34.8 (CH), 21.8 (CH3), 21.2 (CH3), 17.0
(CH3), 16.8 (CH3). HRMS: m/z calcd for C15H20O2Na [M +
Na]: 255.1361; found: 255.1364.
O
O
O
HO
Compound 3: IR (neat): nmax = 1237, 911, 815 cm–1. 1H
NMR (400 MHz, CDCl3): d = 6.92 (1 H, d, J = 7.8 Hz), 6.84
(1 H, s), 6.63 (1 H, d, J = 7.8 Hz), 2.24 (3 H, s), 2.22–2.05 (4
H, m), 1.95–1.83 (1 H, m), 1.69 (3 H, s), 1.09 (3 H, d, J = 6.9
Hz), 1.07 (3 H, d, J = 6.9 Hz). 13C NMR (100 MHz, CDCl3):
d = 149.4 (C), 129.7 (C), 128.8 (CH), 128.7 (C), 123.4 (CH)
115.6 (CH), 111.1 (C), 82.7 (C), 42.7 (CH2), 34.7 (CH), 34.6
(CH2), 21.7 (CH3), 20.7 (CH3), 16.9 (CH3), 16.7 (CH3).
3
O
O
O
HO
4
Scheme 4
Synlett 2008, No. 8, 1199–1201 © Thieme Stuttgart · New York